Novartis

Novartis scores 3rd phase 3 win for ianalumab this week

A day after posting a pair of phase 3 wins for Sjögren's syndrome, Novartis unveiled a late-stage victory in another B-cell-driven autoimmune disease.

James Waldron Aug 12, 2025 5:09am

Novartis scores double phase 3 win in Sjögren's syndrome

Aug 11, 2025 4:33am

Ikena and Inmagene choose combined CEO—Chutes & Ladders

Jul 25, 2025 8:30am

blue tennis court with tennis balls and racquets

Matchpoint nets $60M in new Novartis deal

Jul 24, 2025 12:04pm

parasailing over clouds in Salzburg Austria

Sarepta shakes up C-suite amid org overhaul—Chutes & Ladders

Jul 18, 2025 8:30am

Novartis' ianalumab fails to show promise in dermatology study

Jul 17, 2025 4:28am